Piperacillin and tazobactam exhibit linear pharmacokinetics after multiple standard clinical dosesAUCLAIR, B; DUCHARME, M. P.Antimicrobial agents and chemotherapy. 1999, Vol 43, Num 6, pp 1465-1468, issn 0066-4804Article

Liposomal tobramycin against pulmonary infections of Pseudomonas aeruginosa: a pharmacokinetic and efficacy study following single and multiple intratracheal administrations in ratsMARIER, J. F; BRAZIERS, J. L; LAVIGNE, J et al.Journal of antimicrobial chemotherapy (Print). 2003, Vol 52, Num 2, pp 247-252, issn 0305-7453, 6 p.Article

A population pharmacokinetic model for vancomycin in pediatric patients and its predictive value in a naive populationLAMARRE, P; LEBEL, D; DUCHARME, M. P et al.Antimicrobial agents and chemotherapy. 2000, Vol 44, Num 2, pp 278-282, issn 0066-4804Article

On-line deconjugation of glucuronides using an immobilized enzyme reactor based upon β-glucuronidaseDI MARCO, M. P; FELIX, G; DESCORPS, V et al.Journal of chromatography. B, Biomedical sciences and applications. 1998, Vol 715, Num 2, pp 379-386, issn 1387-2273Article

Pharmacokinetics and Potential Advantages of a New Oral Solution of Levothyroxine vs. other Available Dosage FormsYUE, C. S; SCARSI, C; DUCHARME, M. P et al.Arzneimittel-Forschung. 2012, Vol 62, Num 12, pp 631-636, issn 0004-4172, 6 p.Article

Novel pharmacokinetic modelling of transdermal nitroglycerinAUCLAIR, B; SIROIS, G; ANH HO NGOC et al.Pharmaceutical research. 1998, Vol 15, Num 4, pp 614-619, issn 0724-8741Article

New insights into the pharmacokinetics and metabolism of (R, S)-ifosfamide in cancer patients using a population pharmacokinetic-metabolism modelDI MARCO, M. P; WAINER, I. W; GRANVIL, C. L et al.Pharmaceutical research. 2000, Vol 17, Num 6, pp 645-652, issn 0724-8741Article

6', 7'-Dihydroxybergamottin in grapefruit juice and Seville orange juice : Effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoproteinEDWARDS, D. J; FITZSIMMONS, M. E; SCHUETZ, E. G et al.Clinical pharmacology and therapeutics. 1999, Vol 65, Num 3, pp 237-244, issn 0009-9236Article

Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoinDUCHARME, M. P; SLAUGHTER, R. L; WARBASSE, L. H et al.Clinical pharmacology and therapeutics. 1995, Vol 58, Num 6, pp 617-624, issn 0009-9236Article

The effects of obesity on the pharmacokinetics and pharmacodynamics of glipizide in patients with non-insulin-dependent diabetes mellitusJABER, L. A; DUCHARME, M. P; HALAPY, H et al.Therapeutic drug monitoring. 1996, Vol 18, Num 1, pp 6-13, issn 0163-4356Conference Paper

On-line deconjugation of chloramphenicol-β-D-glucuronide on an immobilized β-glucuronidase column. Application to the direct analysis of urine samplesPASTERNYK, M; DUCHARME, M. P; DESCORPS, V et al.Journal of chromatography. 1998, Vol 828, Num 1-2, pp 135-140, issn 0021-9673Conference Paper

Phenytoin-induced alteration in the N-dechloroethylation of ifosfamide stereoisomersDUCHARME, M. P; BERNSTEIN, M. L; GRANVIL, C. P et al.Cancer chemotherapy and pharmacology. 1997, Vol 40, Num 6, pp 531-533, issn 0344-5704Article

Disposition of intravenous and oral cyclosporine after administration with grapefruit juiceDUCHARME, M. P; WARBASSE, L. H; EDWARDS, D. J et al.Clinical pharmacology and therapeutics. 1995, Vol 57, Num 5, pp 485-491, issn 0009-9236Article

Enantioselective disposition of hydroxychloroquine after a single oral dose of the racemate to healthy subjectsDUCHARME, J; FIEGER, H; DUCHARME, M. P et al.British journal of clinical pharmacology. 1995, Vol 40, Num 2, pp 127-133, issn 0306-5251Conference Paper

Electrophysiologic and electrocardiographic pharmacodynamics of cocaineTISDALE, J. E; DUCHARME, M. P; SHIMOYAMA, H et al.Pharmacotherapy. 1996, Vol 16, Num 3, pp 438-445, issn 0277-0008Conference Paper

Bioavailability of syrup and tablet formulations of cefetamet pivoxilDUCHARME, M. P; EDWARDS, D. J; MCNAMARA, P. J et al.Antimicrobial agents and chemotherapy. 1993, Vol 37, Num 12, pp 2706-2709, issn 0066-4804Article

Through concentrations of cyclosporine in blood following administration with grapefruit juiceDUCHARME, M. P; PROVENZANO, R; DEHOORNE-SMITH, M et al.British journal of clinical pharmacology. 1993, Vol 36, Num 5, pp 457-459, issn 0306-5251Conference Paper

Drug-induced alteractions in serum creatinine concentrationsDUCHARME, M. P; SMYTHE, M; STROHS, G et al.The Annals of pharmacotherapy. 1993, Vol 27, Num 5, pp 622-633, issn 1060-0280Article

Ability of a first-pass pharmacokinetic model to characterize cyclosporine blood concentrations after administrations of sandimmune or Neoral formulationsDUCHARME, M. P; VERRET, L; BROUILLETTE, D et al.Therapeutic drug monitoring. 1998, Vol 20, Num 2, pp 165-171, issn 0163-4356Article

Population pharmacokinetics of nitroglycerin and of its two metabolites after a single 24-hour application of a nitroglycerin transdermal matrix delivery systemAUCLAIR, B; SIROIS, G; ANH HO NGOC et al.Therapeutic drug monitoring. 1998, Vol 20, Num 6, pp 607-611, issn 0163-4356Article

The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitusJABER, L. A; DUCHARME, M. P; EDWARDS, D. J et al.Pharmacotherapy. 1996, Vol 16, Num 5, pp 760-768, issn 0277-0008Article

Vancomycin pharmacokinetics in a patient population : effect of age, gender, and body weightDUCHARME, M. P; SLAUGHTER, R. L; EDWARDS, D. J et al.Therapeutic drug monitoring. 1994, Vol 16, Num 5, pp 513-518, issn 0163-4356Article